Physicians Financial Services’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Sell
12,234
-50
-0.4% -$7.5K 0.48% 47
2026
Q1
$1.88M Hold
12,284
0.51% 43
2025
Q4
$1.69M Sell
12,284
-150
-1% -$19.6K 0.45% 43
2025
Q3
$1.59M Sell
12,434
-200
-2% -$24.4K 0.44% 44
2025
Q2
$1.53M Sell
12,634
-200
-2% -$22.5K 0.46% 43
2025
Q1
$1.43M Sell
12,834
-234
-2% -$24.9K 0.46% 45
2024
Q4
$1.27M Sell
13,068
-250
-2% -$26.7K 0.39% 52
2024
Q3
$1.53M Sell
13,318
-225
-2% -$25.5K 0.48% 48
2024
Q2
$1.44M Hold
13,543
0.47% 51
2024
Q1
$1.31M Sell
13,543
-400
-3% -$41K 0.46% 53
2023
Q4
$1.41M Sell
13,943
-140
-1% -$13.5K 0.53% 48
2023
Q3
$1.43M Hold
14,083
0.59% 45
2023
Q2
$1.42M Buy
14,083
+100
+0.7% +$10K 0.56% 46
2023
Q1
$1.29M Sell
13,983
-100
-0.7% -$8.73K 0.54% 50
2022
Q4
$1.28M Hold
14,083
0.58% 49
2022
Q3
$1.07M Sell
14,083
-100
-0.7% -$8.29K 0.52% 51
2022
Q2
$1.2M Sell
14,183
-25
-0.2% -$2.19K 0.53% 51
2022
Q1
$1.25M Sell
14,208
-325
-2% -$28.1K 0.48% 55
2021
Q4
$1.27M Sell
14,533
-525
-3% -$43.6K 0.47% 55
2021
Q3
$1.23M Sell
15,058
-300
-2% -$27K 0.5% 57
2021
Q2
$1.4M Sell
15,358
-585
-4% -$52.1K 0.57% 50
2021
Q1
$1.36M Buy
15,943
+2,510
+19% +$225K 0.58% 49
2020
Q4
$1.27M Sell
13,433
-277
-2% -$24.2K 0.61% 47
2020
Q3
$1.19M Buy
13,710
+678
+5% +$58.7K 0.6% 47
2020
Q2
$1.14M Buy
13,032
+103
+0.8% +$8.89K 0.63% 46
2020
Q1
$1.07M Sell
12,929
-300
-2% -$26.8K 0.73% 42
2019
Q4
$1.25M Sell
13,229
-100
-0.8% -$8.97K 0.68% 44
2019
Q3
$1.16M Buy
13,329
+200
+2% +$18K 0.66% 44
2019
Q2
$1.2M Sell
13,129
-5,457
-29% -$462K 0.71% 39
2019
Q1
$1.6M Sell
18,586
-111
-0.6% -$8.91K 1% 34
2018
Q4
$1.44M Buy
18,697
+3,989
+27% +$311K 1.05% 31
2018
Q3
$1.14M Sell
14,708
-223
-1% -$16.5K 0.78% 40
2018
Q2
$1.01M Sell
14,931
-228
-2% -$15.7K 0.76% 42
2018
Q1
$1.1M Sell
15,159
-2,790
-16% -$212K 0.88% 38
2017
Q4
$1.35M Hold
17,949
1.03% 33
2017
Q3
$1.38M Hold
17,949
1.13% 32
2017
Q2
$1.34M Sell
17,949
-558
-3% -$39.5K 1.14% 32
2017
Q1
$1.23M Buy
18,507
+1,898
+11% +$126K 1.06% 33
2016
Q4
$1.23M Sell
16,609
-1,284
-7% -$83.3K 1.01% 34
2016
Q3
$1.26M Buy
17,893
+1,228
+7% +$89.5K 1.05% 33
2016
Q2
$1.23M Buy
16,665
+893
+6% +$61.7K 1.08% 31
2016
Q1
$1.02M Buy
15,772
+3,775
+31% +$257K 0.93% 36
2015
Q4
$925K Buy
+11,997
New +$953K 0.85% 37

Other funds holding NVS

Physicians Financial Services's NVS Position: Q2 2026 in Review

Physicians Financial Services reduced its Novartis (NVS) stake by 0.41% in Q2 2026, selling an estimated $7.5K and leaving 12,234 shares worth $1.92M. The position accounts for 0.48% of the portfolio, ranked #47.

Physicians Financial Services first reported a position in NVS in Q4 2015 and has held it in 43 quarters since. 557 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Physicians Financial Services held 12,234 shares of Novartis worth $1.92M as of Q2 2026.
  • Physicians Financial Services sold 50 Novartis shares in Q2 2026, an estimated $7.5K.
  • Novartis made up 0.48% of Physicians Financial Services's portfolio in Q2 2026, its #47 holding.
  • Physicians Financial Services first reported a position in Novartis in Q4 2015 and has held it in 43 quarters since.
  • 557 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Physicians Financial Services's 13F filing for Q2 2026, filed 21 Jul 2026.